BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31980868)

  • 1. Microalbuminuria: a sentinel of neurocognitive impairment in HIV-infected individuals?
    Moulignier A; Viret-Vilayphon AC; Lescure FX; Plaisier E; Salomon L; Lamirel C; Pialoux G;
    J Neurol; 2020 May; 267(5):1368-1376. PubMed ID: 31980868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of peripapillary retinal nerve-fiber-layer thinning in combined antiretroviral therapy-treated, well-sustained aviremic persons living with HIV.
    Lamirel C; Valin N; Savatovsky J; Lescure FX; Alonso AS; Girard P; Vincensini JP; Girard PM; Salomon L; Cochereau I; Moulignier A
    PLoS One; 2020; 15(3):e0229977. PubMed ID: 32155200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief Report: Impact of ART Classes on the Increasing Risk of Cerebral Small-Vessel Disease in Middle-Aged, Well-Controlled, cART-Treated, HIV-Infected Individuals.
    Januel E; Godin O; Moulignier A; Lescure FX; Savatovsky J; Lamirel C; Valin N; Tubiana R; Canestri A; Roux P; Sadik JC; Salomon L; Katlama C; Yazdanpanah Y; Pialoux G; Girard PM; Costagliola D; Assoumou L;
    J Acquir Immune Defic Syndr; 2019 Aug; 81(5):547-551. PubMed ID: 31107300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals.
    Moulignier A; Savatovsky J; Assoumou L; Lescure FX; Lamirel C; Godin O; Valin N; Tubiana R; Canestri A; Roux P; Sadik JC; Salomon L; Abrivard M; Katlama C; Yazdanpanah Y; Pialoux G; Girard PM; Costagliola D;
    Clin Infect Dis; 2018 May; 66(11):1762-1769. PubMed ID: 29244126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
    Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
    BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney function changes and their relation with the progression of cerebral small vessel disease and cognitive decline.
    Jiménez-Balado J; Riba-Llena I; Pizarro J; Palasí A; Penalba A; Ramírez C; Maisterra O; Espinel E; Ramos N; Pujadas F; Serón D; Delgado P
    J Neurol Sci; 2020 Feb; 409():116635. PubMed ID: 31869590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albuminuria and Microalbuminuria as Predictors of Cognitive Performance in a General Population: An 11-Year Follow-Up Study.
    Ekblad LL; Toppala S; Johansson JK; Koskinen S; Sundvall J; Rinne JO; Puukka P; Viitanen M; Jula A
    J Alzheimers Dis; 2018; 62(2):635-648. PubMed ID: 29480195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
    Kooij KW; Vogt L; Wit FWNM; van der Valk M; van Zoest RA; Goorhuis A; Prins M; Post FA; Reiss P;
    J Infect Dis; 2017 Sep; 216(6):622-631. PubMed ID: 28934420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
    Ma Q; Vaida F; Wong J; Sanders CA; Kao YT; Croteau D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; Morgello S; Simpson DM; Heaton RK; Grant I; Letendre SL;
    J Neurovirol; 2016 Apr; 22(2):170-8. PubMed ID: 26407716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection.
    Su T; Schouten J; Geurtsen GJ; Wit FW; Stolte IG; Prins M; Portegies P; Caan MW; Reiss P; Majoie CB; Schmand BA;
    AIDS; 2015 Mar; 29(5):547-57. PubMed ID: 25587908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive Development in Perinatally Human Immunodeficiency Virus-infected Adolescents on Long-term Treatment, Compared to Healthy Matched Controls: A Longitudinal Study.
    Van den Hof M; Ter Haar AM; Scherpbier HJ; van der Lee JH; Reiss P; Wit FWNM; Oostrom KJ; Pajkrt D
    Clin Infect Dis; 2020 Mar; 70(7):1364-1371. PubMed ID: 31106812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals.
    Sanford R; Fellows LK; Ances BM; Collins DL
    JAMA Neurol; 2018 Jan; 75(1):72-79. PubMed ID: 29131878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurocognitive impairments of HIV infected individuals -- preliminary results of a national prevalence study in Hungary].
    Lakatos B; Szabó Z; Bozzai B; Bánhegyi D; Gazdag G
    Ideggyogy Sz; 2014 Nov; 67(11-12):409-14. PubMed ID: 25720243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvascular Dysfunction Is Associated With Worse Cognitive Performance: The Maastricht Study.
    Rensma SP; van Sloten TT; Houben AJHM; Köhler S; van Boxtel MPJ; Berendschot TTJM; Jansen JFA; Verhey FRJ; Kroon AA; Koster A; Backes WH; Schaper N; Dinant GJ; Schalkwijk CG; Henry RMA; Wolfs EML; van Heumen MJA; Schram MT; Stehouwer CDA
    Hypertension; 2020 Jan; 75(1):237-245. PubMed ID: 31735081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-ever acute ischemic strokes in HIV-infected persons: A case-control study from stroke units.
    Stammler R; Guillaume J; Mazighi M; Denier C; Raynouard I; Lapergue B; De Broucker T; Meseguer E; Hosseini H; Leger A; Smadja D; Lamy C; Obadia M; Moulignier A
    Ann Clin Transl Neurol; 2024 Apr; 11(4):916-925. PubMed ID: 38287505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cognitive dysfunction related to Alzheimer disease or cerebral small vessel disease: What's the differences.
    Liang Z; Wu L; Gong S; Liu X
    Medicine (Baltimore); 2021 Aug; 100(34):e26967. PubMed ID: 34449462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive profile of HIV-positive adults on combined antiretroviral therapy: A single-centre study in Serbia.
    Malagurski B; Bugarski Ignjatović V; Marić D; Nikolašević Ž; Mihić L; Brkić S
    Appl Neuropsychol Adult; 2018; 25(6):513-522. PubMed ID: 28665215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Decline in Relation to Psychological Wellbeing and HIV Disease- and Treatment Characteristics in HIV-Infected Patients on cART: A One-Year Follow-Up Study.
    Janssen MAM; Koopmans PP; Kessels RPC
    AIDS Behav; 2017 Jun; 21(6):1728-1734. PubMed ID: 27752871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy.
    Winston A; Stöhr W; Antinori A; Arenas-Pinto A; Llibre JM; Amieva H; Cabié A; Williams I; Di Perri G; Tellez MJ; Rockstroh J; Babiker A; Pozniak A; Raffi F; Richert L;
    HIV Med; 2016 Jun; 17(6):471-8. PubMed ID: 26611175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional brain connectome and its relation to mild cognitive impairment in cerebral small vessel disease patients with thalamus lacunes: A cross-sectional study.
    Qin Y; Zhu W; Liu C; Wang Z; Zhu W
    Medicine (Baltimore); 2019 Oct; 98(40):e17127. PubMed ID: 31577703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.